Strikingly, we find that the inhibition of GRP94 ATPase activity improves AAT monomer secretion and its NE inhibitory activity, while reducing both intracellular polymer load and polymer secretion for most pathogenic AAT variants, including the prominent Z-variant affecting 95% of the AATD population. The gene discussed is DNAH8; the disease is alpha 1-antitrypsin deficiency.